Jonathan Lischalk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Final results from a phase 3 trial with the investigational DCVax-L vaccine show that overall survival was increased both in patients with newly diagnosed glioblastoma as well as recurrent disease.

New yorkUnited statesNew jerseyUnited kingdomIsland schoolCity ofJosephc landolfiLos angelesKeyoumars ashkanJonathan lischalkUniversity of californiaUniversity medical centerKing college hospitalLangone perlmutter cancer centerDepartment of neurosurgeryBiotherapeutics inc